GlassScriptPhysician profile
Juyeon Park
NPI 1417452327
$7,881.18
in general payments reported to CMS, 2019-2025
20 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $4,268 · 2024: $3,173 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,186 · Education: $3,000 · Travel and Lodging: $1,695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.78 |
| Education | $3,000.00 |
| Travel and Lodging | $1,695.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,380.45 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,973.25 | 2023-2025 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Tela Bio, INC. | $732.03 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $260.97 | 2023-2025 | Signia, Ligasure |
| Teleflex LLC | $209.68 | 2023-2024 | Titan Sgs, Quikclot |
| Davol INC. | $186.00 | 2024 | Phasix Mesh |
| Smoky Mountain Surgical LLC | $166.45 | 2024 | |
| Boston Scientific Corporation | $165.90 | 2023 | Axios, Spyglass Discover |
| Sanara Medtech INC. | $155.45 | 2024 | Celleraterx |
| Janssen Biotech, INC. | $124.77 | 2024 | Akeega, Erleada |
| Ethicon US, LLC | $120.74 | 2024 | Echelon Endopath |
| Abbvie INC. | $108.71 | 2024 | |
| Integra Lifesciences Corporation | $88.67 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Novo Nordisk INC | $64.11 | 2025 | Wegovy, Ozempic |
| Smith+Nephew, INC. | $39.08 | 2025 | Grafix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $26.61 | 2025 | Activ.A.C. |
| Humacyte Global, INC. | $26.18 | 2025 | Symvess |
| Lilly USA, LLC | $18.22 | 2023 | Zepbound |
| Rhythm Pharmaceuticals, INC. | $17.02 | 2024 | Imcivree |
| Olympus America INC. | $16.89 | 2023 | Olympus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juyeon Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.